REQUEST A DEMO
Total
USD $0.00
Search more companies

Genomica Oncologica De Colombia S.A.S (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Genomica Oncologica De Colombia S.A.S Profile Updated: September 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Genomica Oncologica De Colombia S.A.S is based in Colombia. The head office is in Valledupar. It operates in the Other Ambulatory Health Care Services industry. The company was established on August 27, 2018. 2 (2020) employees currently work for Genomica Oncologica De Colombia S.A.S. From the latest financial highlights, Genomica Oncologica De Colombia S.A.S reported a net sales revenue increase of 53.18% in 2023. A growth of 39.09% was recorded in its total assets. The net profit margin of Genomica Oncologica De Colombia S.A.S increased by 9.05% in 2023.

Headquarters
Cl 16 15 42 Unidad Medica San Jose Cons
Valledupar; Cesar; Postal Code: 0821

Contact Details: Purchase the Genomica Oncologica De Colombia S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Genomica Oncologica De Colombia S.A.S report to view the information.
Outstanding Shares:
Purchase the Genomica Oncologica De Colombia S.A.S report to view the information.
Incorporation Date:
August 27, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Genomica Oncologica De Colombia S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
53.18%
Total operating revenue
53.18%
Operating profit (EBIT)
130.67%
EBITDA
129.17%
Net Profit (Loss) for the Period
204.55%
Total assets
39.09%
Total equity
49.8%
Operating Profit Margin (ROS)
9.55%
Net Profit Margin
9.05%
Return on Equity (ROE)
16.93%
Debt to Equity Ratio
-13.05%
Quick Ratio
0.32%
Cash Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?